Clinical trial
A Randomized, Open-label Phase I Clinical Study to Evaluate the Systemic Pharmacokinetics and Safety of Atropine Sulfate Eye Drops in Healthy Chinese Volunteers
NCT05855018 is registered in ClinicalTrials.gov with Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Open-label Phase I Clinical Study to Evaluate the Systemic Pharmacokinetics and Safety of Atropine Sulfate Eye Drops in Healthy Chinese Volunteers
- Lead sponsor
- Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- May 9, 2023
- Completion date
- June 30, 2023
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pharmacokinetics